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Abstract
In heterogeneous cohorts and those where censoring by non-primary risks is informative many
conventional survival analysis methods are not applicable; the proportional hazards assumption is
usually violated at population level and the observed crude hazard rates are no longer estimators of
what they would have been in the absence of other risks. In this paper, we develop a fully Bayesian
survival analysis to determine the probabilistically optimal description of a heterogeneous cohort
and we propose a novel means of recovering hazard rates and survival functions ‘decontaminated’
of the effects of any competing risks. Most competing risks studies implicitly assume that risk
correlations are induced by cohort or disease heterogeneity that is not captured by covariates. We
additionally assume that proportional hazards hold at the level of individuals, for all risks, leading
to a generic statistical description that allows us to decontaminate the effects of informative cen-
soring, and from which Cox regression, frailty and random effects models, and latent class models
can all be recovered as special cases. Synthetic data confirm that our approach can map a cohort’s
substructure, and remove heterogeneity-induced false protectivity and false aetiology effects. Ap-
plication to survival data from the ULSAM cohort leads to plausible alternative explanations for
previous counter-intuitive inferences to prostate cancer. The importance of managing cardiovas-
cular disease as a comorbidity in women diagnosed with breast cancer is suggested on application
to survival data from the AMORIS study.
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1 Introduction
The analysis of survival data is often complicated by cohort heterogeneity and informative censoring arising from
competing risks. In this paper, we extend the conventional approaches to modelling a cohort and present a survival
analysis which determines probabilistically the most likely characterisation of a cohort and can provide cause-specific
hazard rates and survival curves ‘decontaminated’ of the effects of informative censoring.
A cohort is subject to informative censoring if the event-times of the primary and non-primary risks are not
statistically independent; a cohort for which this is true is described as being subject to ‘competing risks’. Unfortu-
nately, one cannot infer presence or absence of risk correlations from survival data alone [1, 2], and in many cases the
independence assumption which underpins many survival analysis approaches is expected to be incorrect. Residual
heterogeneity, which is not visible in the covariates, is often a fingerprint of such risk event-time correlations in
cohorts having competing risks. The inference of risk characteristics from survival data in the hypothetical situation
where all other risks were disabled requires that the competing risk problem be addressed [3], that is, it is necessary
to somehow handle contamination by informative censoring. In discussing informative censoring in a cohort, we
shall refer to the crude cause-specific hazard rates and survival functions, in which the influence of competing risks is
present, and we define their decontaminated analogues as the cause-specific decontaminated hazard rates and survival
functions, isolated from the effects of all other risks.
The effective determination of heterogeneity can lead to a more accurate understanding of the characteristics of a
cohort. In clinical epidemiology, diagnosing and disentangling cohort heterogeneity is crucial in many studies where
differences in “case-mix” are considered to be problematic, e.g. in comparing treatment outcomes from different
institutions. Unaccounted for risk correlations can lead to incorrect inferences [4, 5, 6, 7, 8] and the importance
of having reliable epidemiological tools for isolating statistical features even for interrelated comorbid diseases is
increasingly recognised [9]. An understanding of how a modifiable covariate (e.g. taking a particular medication,
consuming a particular food type, smoking, exercising, etc.) having different influences for different groups within a
cohort could prove advantageous for effective monitoring and management of population health. In populations where
longevity is increasing, once relatively uncommon conditions are becoming more prevalent with the development of
more effective therapies to treat competing conditions. Knowledge of the expected survival against such currently
uncommon diseases, decontaminated of the influence of other risks, may provide a useful means of allocating research
and public health resources efficiently.
Simple survival analysis methods, such as Kaplan-Meier estimators [10] and Cox regression [11], are unable to
correctly capture the characteristics of a cohort in the presence of heterogeneity as their successful use requires
proportional hazards across the cohort as a whole. The uncritical use of these techniques can be quite misleading
when the proportional hazards assumption is not satisfied, as demonstrated in Figure 1 (a) for a simulated cohort
modelling false protectivity effects. However, they can offer clues as to the presence of heterogeneity and informative
censoring in a cohort. Inspection of the covariate-conditioned risk-specific Kaplan-Meier estimators can confirm
violation of the proportional hazards assumption, as is clearly evident for the cohort in Figure 1 (b). Differences
between the cumulative incidence [12] and the complement of the corresponding risk-specific Kaplan-Meier estimator
are indicative of competing risks in a cohort e.g. [13], as shown in Figure 1 (c).
Many authors have tried to model residual cohort heterogeneity, usually starting from Cox-type cause-specific
hazard rates, but with additional individualised risk multipliers. If the multipliers do not depend on the covariates we
speak of ‘frailty models’, e.g. [14, 15, 16, 17, 18], and regard them as representing the impact of unobserved covariates,
see e.g. [19]. If they depend on the covariates we would speak of ‘random effects models’, e.g. [20, 5, 21, 22, 23]. If
the distribution of frailty factors takes the form of discrete clusters (latent classes, [24]), we obtain the latent class
models; see e.g. [25] or [26] (which combines frailty and random effects with covariate-dependent class allocation
as in [27]). Further variations include time-dependent frailty factors, and models in which the latent class of each
individual is known. Most frailty and random effects studies, however, quantify only the hazard rate of the primary
risk. They thereby capture some consequences of cohort heterogeneity, but without modelling also the non-primary
risks it is fundamentally impossible to deal with the competing risk problem.
The approach of [28] focuses on parametrising the covariate-conditioned cumulative incidence function of the
primary risk. It is conceptually similar to [11]; both model the primary risk profile in the presence of all risks.
Cumulative incidence functions appear more intuitive than hazard rates; they are directly measurable, and incorpo-
rate also the impact of non-primary risks. However, expressing the data likelihood in terms of cumulative incidence
functions is more cumbersome than in terms of hazard rates. But while [28] quantify risks that compete, they do
not address the competing risk problem. Further developments involve e.g. alternative parametrisations [29, 30],
application to the cumulative incidence of non-primary risks [31], and the inclusion of frailty factors [32].
Another community of authors have focused further on identifying which mathematical constraints or conditions
need to be imposed on multi-risk survival analysis models in order to circumvent the identifiability problem, and
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Figure 1: Effects and signatures of heterogeneity and informative censoring: In (a) an illustration of the dangers of using covariate-
conditioned risk-specific Kaplan-Meier (KM) estimators, SˆKMr , in the presence of competing risks. The estimators for the lower and
upper quartiles (LQ and UQ respectively) of a covariate associated with the primary risk are shown for two simulated cohorts, one in
which there is no informative censoring and another which is subject to a competing risk, with both cohorts sharing identical primary
risk characteristics. These estimators offer an extremely misleading indication of survival against the primary risk in the presence of
informative censoring (i.e. a competing risk), as can be seen by the differences between the estimators in the absence (solid lines) and
presence (dashed lines) of informative censoring. The application of our practical tools to provide decontaminated survival estimators,
free from the effects of the competing risk, to the synthetic cohort data shown here is detailed in Section 3. In (b) the use of the
covariate-conditioned risk-specific Kaplan-Meier estimator to detect the violation of proportional hazards assumption and infer possible
heterogeneity in a cohort. The Kaplan-Meier estimator for prostate cancer (r =PC) risk, conditioned on an individuals smoking status,
is suggestive of heterogeneity in the ULSAM cohort; the estimator would suggest that the survival of smokers is greater than that of ex-
and non-smokers (an alternative view is suggested from our analysis; Section 4). In (c) the empirically measured cumulative incidence,
Fˆr(t), and the complement of the Kaplan-Meier estimator, SˆKMr , for breast cancer (r =BC) and cardiovascular disease (r =CV) death for
women diagnosed with breast cancer from the AMORIS population; the difference between the cumulative incidence and the complement
of the corresponding Kaplan-Meier estimator indicating the presence of competing risks in the cohort.
infer the joint event time distribution unambiguously from survival data. Examples involving survival data with
covariates are [33], and [34]. However, also these studies do not take the step towards decontamination tools or
facilitate interpretation.
In our analysis, we build upon the frailty, random effects, and latent class approaches, to develop a generic model
from which we estimate the relative frailty, covariate association(s), and base hazard rate for each latent class and
for all risks. Additionally, by assuming that informative censoring at the cohort level is a consequence of residual
(disease- or patient-) heterogeneity that is not captured by covariates in populations where only at the level of
individuals are the different risks independent, we are able to derive exact formulae for decontaminated hazard rates
and cause-specific survival functions. Our assumption of such heterogeneity-induced informative censoring is much
weaker than assuming risk independence, yet it still imposes sufficient constraints to decontaminate from the effects
of informative censoring. Furthermore, our analysis offers improvement over existing approaches in several distinct
ways: In choosing to model all risks simultaneously more information can be extracted from cohort data in which risk
correlations are present; in such circumstances, the application of an analysis approach which models the primary
risk only is akin to choosing to not fully utilise the information available from the cohort data. Our analysis also
introduces a fully Bayesian model selection for the determination of the optimal characterisation of a cohort.
In Section 2 we classify the distinct levels of “risk complexity” in a cohort from the competing risk perspective and
define precisely what we mean by heterogeneity-induced informative censoring before presenting the mathematical
development behind our approach to survival analysis.
In Section 3 the effectiveness of our analysis to characterise heterogeneous cohorts is demonstrated; the results
obtained on application of our analysis to synthetic survival data, simulating a variety of heterogeneous cohorts
and informative censoring, are presented and compared with those obtained from Kaplan-Meier estimators and Cox
regression.
In Sections 4 and 5 our analysis is applied to real survival data related to prostate and breast cancer, from the
ULSAM longitudinal cohort [35, 36] and AMORIS study [37, 38], respectively. The application to the ULSAM data
leads to appealing and transparent new explanations for previously counter-intuitive inferences. Age-related survival
differences between women diagnosed with breast cancer were found on application to data from the AMORIS cohort.
In Section 6 we summarise our findings.
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2 Heterogeneity-induced informative censoring
In this section we introduce our survival analysis based on the assumption that risk event time correlations, if
present, are caused by residual cohort heterogeneity. This assumption is much weaker than that of assuming risk
independence, but it does allow us to overcome informative censoring and leads to an intuitive and transparent
parametrisation of hazard rates, and makes quantities decontaminated of its effects accessible.
The relationships between the event probabilities in a cohort and those of its members are critical to any analysis
that seeks to address the issue of heterogeneity and are formalised in Section 2.1. In Section 2.2 the extent to which
different risk (in)dependence assumptions limit survival analysis is explored; existing survival analysis methods and
our heterogeneity-induced competing risk approach are compared in terms of the “risk complexity” of cohorts to
which they can be applied. Decontaminated cause-specific survival functions and hazard rates are presented in
Section 2.3, the difference between the decontaminated quantities and their respective crude counterparts providing
a means of quantifying the severity of informative censoring in a cohort. The development of our latent class approach
to modelling heterogeneous cohorts is outlined in Section 2.4 (with further details and identities given in Appendix A)
and details of our Bayesian approach to the determination of the optimal characterisation of a cohort are given in
Section 2.5. In Section 2.6 the various outputs of our analysis and their benefits are discussed.
2.1 Connection between cohort level and individual level descriptions
The standard mathematical relations of survival analysis are derived directly from the joint event time distribution
and hold irrespective of whether we have a large or small cohort, or even a single individual. Below we formalise a
number of quantities of interest, both for the individual and for the cohort as a whole, and the relationships between
them; the index i is used to denote those personalised quantities specific to individual i, with no such index being
present for cohort-specific quantities.
We imagine a cohort of N individuals who are each subject to R true risks, labelled by r = 1 . . . R, and an
end-of-trial censoring event denoted by r = 01. The joint event time distribution P(t0, . . . , tR) describes, for the
cohort as a whole, the probability of the event times (t0, . . . , tR), where tr ≥ 0 is the time at which risk r triggers
an event2, with the personalised event time distribution being denoted by Pi(t0, . . . , tR). The cohort level risk event
time distribution is a direct average of the personalised event risk event time distributions, such that P(t0, . . . , tR) =
N−1
∑
i Pi(t0, . . . , tR). It is an estimator of the joint event time probability for the greater population if the cohort
is representative. Throughout this paper we shall assume that N is sufficiently large to ensure that the differences
between P(t0, . . . , tR) and the population’s event time distribution are immaterial and that inferences made about
the cohort are also true for the population.
In the interest of readability it should be assumed that products and summations over the risks run over the
end-of-trial censoring risk and the true risks, such that r = 0, . . . , R, shall be written as
∏
r and
∑
r respectively;
should a particular risk r′ be excluded then the product shall be written as
∏
r 6=r′ . Similarly, summations over the
cohort shall run over all members, labelled by i = 1, . . . , N , are written as
∑
i.
The crude cause-specific hazard rate, that is the probability per unit time that given failures occur at time t if until
then none of the possible events has yet occurred, follows from the joint event time distributions. The personalised
cause-specific hazard rate, hir(t), is given by,
hir(t) =
1
Si(t)
∫ ∞
0
. . .
∫ ∞
0
dt0 . . . dtR Pi(t0, . . . , tR)δ(t− tr)
∏
r′ 6=r
θ(tr′ − t), (1)
where the delta-distribution δ(x) is defined by the identity
∫∞
−∞dx δ(x)f(x) = f(0), the step function is defined as
θ(x > 0) = 1 and θ(x < 0) = 0, and the personalised survival function Si(t) is given by Si(t) = e
−∑r ∫ t0 ds hir(s). The
personalised probability density, Pi(t, r), to find the earliest event occurring at time t and corresponding to risk r is
given by Pi(t, r) = h
i
r(t)e
−∑r′ ∫ t0 ds hir′ (s).
At the cohort-level, analogous relations define the cause-specific hazard rate, hr(t), survival function, S(t), and
time-risk event probability, P (t, r), for the cohort as a whole; these relations are of identical form to the relations
above though obviously cohort-level quantities replace individual-specific quantities. Typically, however, it is the
characterisation of the cohort given the survival analysis data for the cohort that is of interest; to achieve this we
1For the structure of the theory there is no difference between censoring due to alternative risks and censoring due to trial termination.
2This starting point is not fully general. It assumes that all risks will ultimately lead to failure. One can include events with a finite
chance of not happening at any time, by adding for each risk r a binary variable τr to indicate whether or not the calamity button is
pressed at time tr.
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require the covariate-conditioned cause-specific hazard rates and survival functions. The covariate-conditioned risk
event time probability distribution P(t0, . . . , tR|z) describes the risk event time statistics of the sub-cohort of those
individuals i that have covariate vector zi = z. At the cohort level, the covariate-conditioned cause-specific hazard
rate is given by,
hr(t|z) = 1
S(t|z)
∫ ∞
0
. . .
∫ ∞
0
dt0 . . . dtR P(t0, . . . , tR|z)δ(t− tr)
∏
r′ 6=r
θ(tr′ − t), (2)
where the covariate-conditioned survival function is given by S(t|z) = e−
∑R
r′=0
∫ t
0
ds hr′ (s|z). The covariate-conditioned
risk event time probability density is then given by P (t, r|z) = hr(t|z)e−
∑R
r′=0
∫ t
0
ds hr′ (s|z).
The connection between the cohort-level and personalised risk event time distributions is simple; accounting for
covariate-conditioning, the cohort level risk event time distribution is the average of the personalised event time
distributions of those individials with zi = z, such that P(t0, . . . , tR|z) =
∑
i, zi=z
Pi(t0, . . . , tR)/
∑
i, zi=z
1.
The relationship between quantities at the cohort and individual level is simple for those which depend linearly
on the risk event time distribution. The cohort-level survival function is simply the average over the cohort of
the individual survival functions, S(t|z) = ∑i, zi=z Si(t)/∑i, zi=z 1 and the risk event time probability density is
P (t, r|z) = ∑i, zi=z Pi(t, r)/∑i, zi=z 1. In contrast, quantities which depend on the risk event time distribution
in a more complicated way, such as the crude cause-specific hazard rates, and cohort-level quantities are not direct
averages over their individual level counterparts. The cohort level cause-specific hazard rates, for instance, are given
by (see appendix A.1 for details),
hr(t|z) =
∑
i,zi=z
hir(t)e
−∑R
r′=0
∫ t
0
ds hi
r′ (s)∑
i,zi=z
e−
∑R
r′=0
∫ t
0
ds hi
r′ (s)
. (3)
The cause-specific cumulative incidence function, Fr(t), describes the probability that event r has been observed
at any time prior to time t, and is given by,
Fr(t) =
∫ t
0
dt′ S(t′)hr(t′). (4)
Although Fr(t) refers to risk r specifically, it can be heavily influenced by other risks. If it is small, this may be
because event r is intrinsically unlikely, or because it tends to be preceded by events r′ 6= r. One cannot tell.
2.2 Risk complexity in heterogeneous cohorts
In this section we explore the the consequences of event time risk correlations and cohort-level heterogeneity. One
always allows cohorts to be heterogeneous in terms of covariates; we refer here to heterogeneity in the relation between
covariates and risks.
A homogeneous cohort is one in which the relationship between an individual’s covariates and risk is uniform
throughout the cohort. In a homogeneous cohort the personalised event time distribution Pi(t0, . . . , tR) can depend
on i only via zi as such there exists a function Q(t0, . . . , tR, z) such that Pi(t0, . . . , tR) = Q(t0, . . . , tR, zi) is true
for all individuals in the cohort. In such a cohort there can be no informative censoring and the crude and true
cause-specific hazard rates and survival functions are identical.
In heterogeneous cohorts individuals have further relevant features which are not captured by their covariates.
A consequence of these further features is that for such cohorts there no longer exists a function which, for all
individuals in the cohort, maps between an individual’s covariates and their personalised event time distribution.
These additional features impact upon their risks. Here one will observe a gradual ‘filtering’: high-risk individuals will
drop out early, causing time dependencies at cohort level that have no counterpart at individual level. For instance,
even if all individuals have stationary hazard rates, one would according to (3) still find time dependent crude cohort
level hazard rates. Here, having uncorrelated individual level risks no longer implies having uncorrelated covariate-
conditioned cohort level risks. It is quite possible to have Pi(t0, . . . , tR) =
∏
r Pi(tr), but still P(t0, . . . , tR|z) 6=∏
r P(tr|z).
Risk event time correlations in a cohort can be generated at different levels. There is a natural hierarchy of
cohorts in terms of risk complexity, as summarised in Table 1, with implications for the applicability of the different
survival analysis methods.
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Table 1: Risk complexity to capture cohort heterogeneity, risk event-time correlations, and competing risks
Risk complexity Individual Cohort
I
Homogenous cohort
No competing risks at individual level
No competing risks at cohort level
Pi(t0, . . . , tR) =
∏
r P(tr|zi) P(t0, . . . , tR|z) =
∏
r P(tr|z)
II
Heterogeneous cohort
No competing risks at individual level
No competing risks at cohort level
Pi(t0, . . . , tR) =
∏
r Pi(tr) P(t0, . . . , tR|z) =
∏
r P(tr|z)
III
Heterogeneity-induced competing risks
No competing risks at individual level
Cohort level competing risks
Pi(t0, . . . , tR) =
∏
r Pi(tr) P(t0, . . . , tR|z) 6=
∏
r P(tr|z)
IV
Heterogeneous cohort
Individual level competing risks
Cohort level competing risks
Pi(t0, . . . , tR) 6=
∏
r Pi(tr) P(t0, . . . , tR|z) 6=
∏
r P(tr|z)
Assuming statistically independent risk event times at cohort level underlies both Kaplan-Meier estimators and
Cox regression, and is seen only in those cohorts with risk complexity levels I and II. At level II there is still no
competing risk problem, but heterogeneity may demand parametrisations of crude cohort level primary hazard rates
that could be more complex than those of Cox, which is the rationale behind frailty and random effects models, and
the latent class models of [26]. All these approaches still only model the primary risk, and therefore cannot handle
cohorts beyond level II.
In this paper we shall focus on developing survival analysis tools to investigate cohorts with risk complexity level
III, in which the event times of all risks are assumed to be statistically independent for each individual but residual
heterogeneity leads to risk correlations at cohort level. In such cohorts the correlations between cohort level event
times have their origin strictly in correlations between disease susceptibilities and covariate associations of individuals,
for example, someone with a high hazard rate for a disease A may also be likely to have a high hazard rate for event
B, for reasons not explained by the covariates. At this level of risk complexity competing risks phenomena shall be
observed as the risk correlations at cohort level will cause informative censoring.
Cohorts of risk complexity level IV are the most complex and difficult to model, with the event times of different
risks assumed to be correlated at both individual and cohort level, and shall not be explored in this paper.
2.3 Separating direct from indirect associations and quantifying informative censoring
The assumption of heterogeneity-induced competing risks, being that the event times of all risks are statistically
independent for each individual in the cohort but not for the cohort as a whole (risk complexity level III in our classi-
fication above), allows us to investigate analytically the effects of informative censoring. This additional assumption
addresses the issue of identifiabilty [1] and, with the risk event time marginal distributions now accessible, it becomes
possible to develop expressions not only for the crude cause-specific hazard rates and survival function but also for
their decontaminated counterparts.
The personalised cause-specific event time probability given the assumption of risk independence at the individual
level is given by Pi(tr) = h
i
r(t)e
− ∫ t
0
ds hir(s). The covariate-conditioned cohort-level risk event time marginals are
therefore given by P(tr|z) =
∑
i,zi=z
hir(t)e
− ∫ t
0
ds hir(s)/
∑
i,zi=z
1, and can be used to develop expressions for the
decontaminated survival functions and hazard rates3.
The crude cause-specific hazard rates which would have been found if all risks had been independent, hr(t|z),
and their decontaminated counterparts, h˜r(t|z), are given by,
hr(t|z) =
∑
i,zi=z
hir(t)e
−∑R
r′=0
∫ t
0
ds hi
r′ (s)∑
i,zi=z
e−
∑R
r′=0
∫ t
0
ds hi
r′ (s)
, h˜r(t|z) =
∑
i,zi=z
hir(t)e
− ∫ t
0
ds hir(s)∑
i,zi=z
e−
∫ t
0
ds hir(s)
. (5)
The crude and decontaminated cause-specific hazard rates will generally have different values. In the decontaminated
cause-specific hazard rate, h˜r(t|z), the probability that individual i survives until time t is given by exp[−
∫ t
0
ds hir(s)].
The probability of survival until time t for individual i in the crude cause-specific hazard rate, hr(t|z), depends on
all risks.
3The decontaminated survival functions and hazard rates follow from S˜r(t|z) =
∫∞
t dtr P(tr|z) and h˜r(t|z) = − ddt log S˜r(t|z).
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Table 2: Personalised cause-specific hazard rates, for each of the R active risks, to capture latent cohort heterogeneity
M = 1
Heterogeneous frailties
Homogeneous associations
Homogeneous base hazard rates
hir(t) = λr(t)e
β`0r +
∑
µ β
µ
r z
µ
i
M = 2
Heterogeneous frailties
Heterogeneous associations
Homogeneous base hazard rates
hir(t) = λr(t)e
β`0r +
∑
µ β
`µ
r z
µ
i
M = 3
Heterogeneous frailties
Heterogeneous associations
Heterogeneous base hazard rates
hir(t) = λ
`
r(t)e
β`0r +
∑
µ β
`µ
r z
µ
i
The crude cause-specific survival function, Sr(t|z), and its decontaminated counterpart, S˜r(t|z), are given by,
Sr(t|z) = e−
∫ t
0
ds hr(s|z), S˜r(t|z) =
∑
i,zi=z
e−
∫ t
0
ds hir(s)∑
i,zi=z
1
. (6)
The decontaminated cause-specific survival function, S˜r(t|z), depends only on the risk r, whereas its crude
counterpart depends on all risks through the crude hazard rate hr(t|z).
Hence the assumption that competing risks (if present) are induced by heterogeneity leads to relatively simple
formulae for the decontaminated cause-specific quantities of interest and for the likelihood of observing individual
survival data. What remains is to identify the minimal level of description required for evaluating these formulae,
and to determine how the required information can be estimated from survival data.
2.4 Modelling the heterogeneous cohort
In this section we shall develop our latent class model. At the heart of our model are the personalised cause-specific
hazard rates, hir(t), being of the Cox form and obeying the assumption of proportional hazards.
In constructing our latent class framework, we assume a heterogeneous cohort to be comprised of L sub-cohorts,
or latent classes, labelled by ` = 1, . . . , L. Each individual from the cohort must belong to one of the latent classes;
as such the classes are discrete, no class can contain a member from any other class, and together the classes contain
all of the individuals in the cohort. Each class obeys the proportional hazards assumption although the cohort
collectively need not.
The personalised cause-specific hazard rates shall depend on cause-specific and possibly class-specific frailty,
association, and base hazard rate parameters. The frailty parameters, β`0r , capture the impact of unobserved variables
within class ` for risk r, i.e. effects that cannot be attributed to the included covariates directly, the association
parameters, β`µr , quantify how strongly each of the µ = 1, . . . , P covariates influence the personalised hazard rate,
and the base hazard rate, λ`r(t), describes the cause-specific personalised hazard rate for an individual from class `
having exactly average covariate values. Inevitably, modelling all risks and their correlations leads to models having
more parameters than those which model only the primary risk. In an effort to avoid overfitting, three variants of
the personalised cause-specific hazard rates are introduced, with differing degrees of heterogeneity, as summarised in
Table 2.
When applying our latent class framework to describe cohort-level quantities of interest, such as the cause-
specific survival and cumulative incidence functions, those quantities involving the individualised hazard rates will
be expressed in terms of the variables of the latent class model; summations over the individuals in the cohort become
summations over the latent classes, the relative influence of each class depending on the fraction of individuals from
the cohort belonging to that class. Representing the collection of those individuals belonging to class ` by the variable
I`, it follows that a summation over all individuals in the cohort,
∑
i,zi=z
, becomes a summation over the latent
classes and their membership, of the form
∑
`
∑
i∈I`,zi=z. Those quantities expressed through summations over the
individualised cause-specific hazard rates, hir(t), can then be written as summations over covariate-conditioned class-
and cause-specific hazard rates, h`r(t|z), as follows,
∑
i,zi=z
f(hir(t))∑
i,zi=z
1
=
∑
`
∑
i∈I`,zi=z f(h
`
r(t|z))∑
`
∑
i∈I`,zi=z 1
=
∑
`(n`(z)/p(z)N)f(h
`
r(t|z))∑
`(n`(z)/p(z)N)
=
∑
`
w`(z)f(h
`
r(t|z)), (7)
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where the class membership fraction, w`(z), given by the quantity n`(z)/p(z)N , follows from the fraction of individ-
uals from the cohort who belong to class ` and have covariates z (where p(z) represents the population probability of
the covariate vector zi being equal to z). The class membership fractions are subject to the constraint
∑
` w`(z) = 1.
In this paper, to avoid further complexity the class membership fractions are chosen to be independent of the
covariates, this amounts to the assumption that all sub-cohorts have identically distributed covariates.
The various crude and decontaminated quantities which describe a cohort are given below in terms of our latent
class parametrisation for the fully heterogeneous variant of the individualised cause-specific hazard rate (M = 3);
corresponding expressions are easily obtained for the simpler model variants on substitution of class-independent
association(s) (M = 1) and class-independent base hazard rate(s) (M = 2) as appropriate. To aid readability
the following compact notation is used: the effect of the frailty and associations for each true risk r and class `
are summarised by the product β`r · z = β`0r +
∑
µ β
`µ
r z
µ, the time integrals can be factorised and denoted by
Λ`r(t) =
∫ t
0
ds λ`r(s) as the base hazard rates contain all time dependencies. The end-of-trial risk is assumed not to
depend on the covariates, accordingly the class-independent associations for the censoring risk are defined to be zero
β0 = 0. Summations over the covariates run over all P covariates, labelled by µ = 1, . . . , P , and shall be written as∑
µ.
In their parametrised form, the crude and decontaminated hazard rate expressions for the true risks r = 1, . . . , R
are given by,
hr(t|z) =
∑
` w` λ
`
r(t)e
β`r·z−
∑R
r′=1 exp(β
`
r′ ·z)Λ`r′ (t)∑
` w` e
−∑R
r′=1 exp(β
`
r′ ·z)Λ`r′ (t)
, h˜r(t|z) =
∑
` w` λ
`
r(t)e
β`r·z−exp(
ˆβ
`
r·z)Λ`r(t)∑
` w` e
− exp(β`r·z)Λ`r(t)
. (8)
The corresponding crude and decontaminated survival functions are given by,
Sr(t|z) = exp
(
−
∫ t
0
ds hr(s|z)
)
, S˜r(t|z) =
∑
`
w` e
− exp(β`r·z)Λ`r(t). (9)
Once more, it is clear that as the crude cause-specific hazard rate is influenced by all risks then the crude cause-
specific survival function shall be also. In Appendix A.2 the crude and decontaminated survival are shown to be
identical in the case where there is one risk only, i.e. in the absence of any potential informative censoring.
The cause-specific cumulative incidence functions using our latent class model are given by,
Fr(t|z) =
∫ t
0
dt′ e−Λ0(t
′)
∑
`
w` λ
`
r(t
′)eβ
`
r·z−
∑R
r′=1 exp(β
`
r′ ·z)Λ`r′ (t′). (10)
It is noteworthy that our approach leads to an intuitive and easily interpreted formulation of the cause-specific
cumulative incidence in which the role of all model parameters is completely transparent.
Our approach also offers retrospective determination of class membership probability for an individual using their
covariates, z, and survival information, (t, r). Following Bayesian arguments (as detailed in Appendix A.3), the
probability that individual belongs to class `, given their covariates and survival information, is given by,
P (`|t, r, z) = w` λ
`
r(t)e
β`r·z−
∑R
r′=1 exp
(
β`r′ ·z
)
Λ`
r′ (t)∑L
`′=1 w`′ λ
`′
r (t)e
β`
′
r ·z−
∑R
r′=1 exp
(
β`
′
r′ ·z
)
Λ`
′
r′ (t)
. (11)
The search for informative new covariates could be aided by retrospective class assignment, increasing our ability to
predict personalised risk in heterogeneous cohorts. Such new covariates are expected to be features that patients in
the same class have in common.
Determination of the optimal characterisation of a cohort, that is the optimal values of the latent class fractions
and the frailties, associations, and base hazard rates for each class and each risk, given the available data, is described
in the next section.
2.5 Characterisation of cohort heterogeneity
The Bayesian formalism has been used to determine the optimal characterisation of a cohort. The most appropriate
latent class model variant, the most suitable number of latent classes, and the form of the base hazard rates are
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all unknown at the outset of an analysis, so their optimal values and the corresponding optimal class membership
weightings, frailties, associations, and base hazard rates all need to be determined.
The term ‘model’ shall be used to describe the combination of a particular number of latent classes, L, a particular
form of the base hazard rates realised by a spline construction having K anchored time points, and a particular
parametrisation of the personalised hazard rates, M , and shall be denoted by HKLM . The parameter vector, θHKLM ,
shall denote the model parameters (i.e. the class membership fractions, the frailty, association, and base hazard rate
parameters) of the model HKLM . The expressions developed below apply for the fully heterogeneous personalised
cause-specific hazard rate (M = 3); equivalent expressions for the simpler model variants (M = 1, M = 2) are easily
obtained on substituting class-independent base hazard rate(s) and association(s) as appropriate.
The probability density to find the earliest event occurring at time t corresponding to risk r provides the link
between our latent class model parameters and the observed survival data. The probability density for an individual
with covariate vector z to report (t, r) is given by,
P (t, r|z) = e−Λ0(t)
∑
`
w` λ
`
r(t)e
β`r·z−
∑R
r′=1 exp(β
`
r′ ·z)Λ`r′ (t), (12)
where the parameters are those familiar from the fully-heterogeneous personalised hazard rate (M = 3) defined in
Table 2. The data likelihood, P (D|θHKLM ) =
∏
i P (ti, ri|zi,θHKLM ), gives the joint probability of the event times ti
and risk ri for every individual in the cohort, conditioned on their covariates, zi, and the model parameters, θHKLM ,
for the model HKLM . The task of identifying the optimal characterisation of a cohort is clear; it is necessary to find
the most probable parameter values, θ?HKLM , of the most probable model, H?KLM .
The Bayesian formalism is first applied to determine the optimal parameter values, θ?HKLM , for each modelHKLM . The posterior distribution gives the probability of the model parameters, θHKLM , conditioned on the cohort
survival data, D, and is given by P (θHKLM |D) = Z−1HKLM exp(L(θHKLM , D)), where the log-likelihood is defined
as L(θHKLM , D) = log(P (D|θHKLM )P (θHKLM )), the normalisation constant is denoted by ZHKLM , and the prior
distribution over the model parameters is given by P (θHKLM ) (Appendix A.4). The contribution to the log-likelihood
from the data-likelihood, for the fully heterogeneous model variant (M = 3), is given by,
logP (D|θHKLM ) = −
∑
i
Λ0(ti) +
∑
i
log
[∑
`
w` λ
`
ri(ti)e
β`ri ·zi−
∑R
r=1Λ
`
r(ti) exp(β
`
r·zi)
]
. (13)
In this work, maximum a posteriori parameter estimation (MAP) has been used; the optimal parameter values being
those which maximise the posterior probability.
Bayesian model selection is used to determine the most probable model, H?KLM , given the cohort survival data, D,
from an ensemble of models4, where all models HKLM are given identical prior probability P (HKLM ). In pursuing
this approach, the optimal model is that which is supported by the greatest “evidence” P (HKLM |D), which is here
proportional to the posterior normalisation constant ZHKLM =
∫
dθHKLM P (D|θHKLM ,HKLM )P (θHKLM |HKLM )
for that model. In this work a Gaussian approximation to the posterior has been used such that ZHKLM may be
determined without the requirement for computationally expensive numerical integration (Appendix A.5), but can
be determined from the optimal model parameter values, θ?HKLM , and shall be written as ZHKLM = Z(θ
?
HKLM ).
In practice, to find the optimal characterisation of a cohort, θ?H?KLM , requires that the optimal parameter values
for each of the models being compared are first determined and then the model supported by the greatest evidence is
identified. The optimal parameter values, θ?HKLM , are determined for every model before the optimal model, H?KLM ,
from the ensemble is determined, according to the following algorithm,
H?KLM = arg maxHKLM
[
Z(θ?HKLM )
]
, θ?HKLM = arg maxθHKLM
[P (D|θHKLM )P (θHKLM )] . (14)
2.6 Practical tools for survival analysis
Implementation of the analysis protocol described above (Section 2.5) has been realised in our software package,
ALPACA (Advanced Latent Class Prediction And Competing Risk Analysis), using the C programming language.
The optimal frailty, association, and base hazard rate parameters for each model are located by MAP estimation
using a stochastic refinement of the downhill simplex method [39]. Numerical estimation of the curvature of the
posterior distribution around the location of maximum probability enables both the error bars for the parameter
4The ensemble of models is assumed to contain the actual model underlying the true cohort sub-structure.
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estimates and the model “evidence” to be determined. As the search for the optimal parameter values is achieved
using a stochastic optimization algorithm, and as the task of searching the parameter space becomes more difficult
as the number of latent classes is increased and the greater the complexity of the personalised hazard rate model
and base hazard rate, this procedure is typically performed multiple times and the overall optimal characterisation
is selected.
A cohort’s survival data is pre-processed before application of our analysis algorithms. This pre-processing
involves the linear rescaling of the raw covariate values such that the distribution of their transformed counterparts
correspond to a zero average and unit variance distribution, equivalent to the definition of Z-scores. Missing data
values are imputed according to the average of those values which are available. The parameter estimates obtained
using our analysis can be translated to the more familiar language of hazard ratios (HR), 95% confidence intervals
(CI), and p-values, as a consequence of such data pre-processing. An additional benefit of this pre-processing is that
the magnitudes of the effects for different associations can be directly compared.
The hazard ratio, HRµ, associated with covariate µ, follows from generalising the concept to a balanced co-
hort5, and can, as a consequence of our normalisation of covariates, be computed from the estimated association
parameter βµ according to the relation HRµ = e
2βµ . The lower and upper bounds, HR−µ and HR
+
µ respectively,
of the 95% confidence interval, CIµ = [HR
−
µ ,HR
+
µ ], for the hazard ratio associated with covariate µ are related to
the estimated association parameter βµ and its uncertainty σµ by the expressions HR
−
µ = exp(2(βµ − 1.96σµ)) and
HR+µ = exp(2(βµ + 1.96σµ)) respectively. The p-value is approximated from our parameter estimates according to
the relation pµ = 1− erf(|βµ|/
√
2σµ) where |βµ| denotes the magnitude of the estimated association parameter and
the error integral is given by erf(t) = (2/
√
pi)
∫ t
0
dx e−x
2
.
Survival curves, cumulative incidence curves, and retrospective class allocation for each individual are all possible
once the optimal frailty, association, and base hazard rate parameters have been determined. The presence of
informative censoring in a cohort can be deduced from observing differences between the crude and decontaminated
survival curves; the magnitude of any such differences being indicative of the extent to which competing risks mask
the true cause-specific survival. False protectivity effects should be suspected if the crude survival function exceeds
the decontaminated survival function; the opposite being suggestive of the influence of false exposure in the cohort
data.
In a heterogeneous cohort, the class-specific decontaminated survival may offer valuable insight into the expected
progression of individuals belonging to each of the latent classes. Expressing the decontaminated cause-specific
survival (9), S˜r(t|z), as the weighted sum of cause- and class-specific survival, S˜`r(t|z), as given by,
S˜`r(t|z) = e− exp(β
`
r·z)Λ`r(t), (15)
allows the class-specific decontaminated survival for each of the latent classes to be compared. Similarly, the cause-
specific cumulative incidence function (10) can be expressed as a weighted sum of its class-specific components,
F `r (t|z), given by,
F `r (t|z) =
∫ t
0
dt′ e−Λˆ0(t
′) λˆ`r(t
′)e
ˆβ
`
r·z−
∑R
r′=1 exp(
ˆβ
`
r′ ·z)Λˆ`r′ (t′), (16)
such that Fr(t|z) =
∑
` w`F
`
r (t|z). The class- and cause-specific cumulative incidence provides information as to the
relative occurrence of events for each latent class and each cause at any time during the trial.
Retrospective class assignment, by identification of the most probable latent class to which an individual be-
longs using (11), can offer additional insight into differences between latent classes. Retrospectively allocated class-
conditioned time-to-event distributions may offer clues as to the expected survival time for members of the different
classes. The detection of differences between covariate distributions for those individuals retrospectively assigned to
each latent class offers a potentially powerful means of identifying novel informative covariates.
3 Application to synthetic survival data
In this section the results of the application of our algorithms to synthetic data (see Appendix B) simulating a variety
of conditions are presented. The effectiveness of our algorithm to successfully characterise a heterogeneous cohort
having three latent classes, two of which differ only in their base hazard rates is demonstrated in Section 3.1. In
5It is not possible to capture risk in a single number for non-binary covariates.
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Table 3: Modelling a heterogeneous cohort: The parameters used to generate synthetic data modelling a cohort
having three latent classes, one real risk, and with end-of-trial censoring at time t = 20. The frailty parameter, β`0r ,
for each latent class has been set to zero.
Cohort A: (L = 3,M = 3)
Heterogeneity and class-dependent base hazard rates
Class, ` = 1 Class, ` = 2 Class, ` = 3
w` 1/3 1/3 1/3
λ`1(t) 3/10 e
t/4/100 1/10
β`11 2 2 -2
β`21 0 0 0
β`31 0 0 0
Section 3.2 the ability of our analysis to accurately characterise a cohort in the presence of heterogeneity-induced
informative censoring is shown, the differences between the crude and decontaminated survival curves indicating the
influence of competing risks.
The model space for the analysis of each synthetic data set covered all combinations of latent classes between one
and four, base hazard rate complexity between one and eight, and for each of the three variants of the personalised
hazard rate. The optimal parameter estimates were obtained for each model at least five times and the model with
the greatest overall evidence identified to provide the optimal characterisation for each of the synthetic data sets.
As the class membership of all individuals is known when using simulated cohort data it is also possible to quantify
the accuracy of Bayesian retrospective class allocation; the effectiveness of class identification using our algorithm
(11) is quantified by calculating the fraction of correctly assigned individuals and the quality of allocation can be
expressed for each class, q`, or for the cohort as a whole, q. It is important to note that, even if all parameters were
known exactly, due to the stochasticity of event times class allocation will never be perfectly accurate6.
3.1 Revealing heterogeneity and cohort sub-structure
Our analysis is now applied to data modelling a heterogeneous cohort having three latent classes (L = 3) but free
of the effects of informative censoring. The characteristics of Cohort A are given in Table 3; the three classes are
of equal size, each individual i has three covariates (z1i , z
2
i , z
3
i ) and is subject to either one real risk or end-of-trial
censoring at time t = 20. The personalised cause-specific hazard rates of individuals in Cohort A have class-dependent
associations and base hazard rates (i.e. are of type M = 3). The associations of individuals belonging to classes
` = 1 and ` = 2 are identical; the classes differ only in their base hazard rates, the base hazard rate of class ` = 1 is
time-independent, the base hazard rate of class ` = 2 increases exponentially with time. The base hazard rate of the
third class ` = 3 is time-independent, though it differs from that of the first class.
The characterisation of such a cohort is challenging even in the absence of informative censoring; to successfully
characterise the cohort any analysis must be able to identify the three latent classes and distinguish between two
classes which vary from each other only in their base hazard rate. The effectiveness of our analysis to characterise
Cohort A is summarised in Figure 2, which shows the optimal estimated associations and base hazard rates for data
set sizes N = 20000, N = 2000, and N = 200. It is evident (Figure 2) that the association parameters of Cohort
A were accurately estimated for data set sizes N = 2000 and N = 20000, and that the estimated and true base
hazard rates are sufficiently close that the optimal model can be considered as providing a good characterisation of
the cohort structure. Although it is clear that a sample size of N = 200 is insufficient for Cohort A to be accurately
characterised, it is noteworthy that despite such a meagre sample size our analysis correctly reports that the cohort
is comprised of three latent classes and the estimated associations are accurate (within the estimated uncertainty)
for covariates 2 and 3 for all three classes, and are accurate for classes 1 and 3 for covariate 1.
The optimal models reported for data set sizes N = 20000 and N = 2000 were H?KLM = (L = 3,M = 3,K = 4)
and H?KLM = (K = 3, L = 3,M = 3) respectively. In total, 23 parameters (two weights, and for each of the three
latent classes one frailty, three associations, and three modifiable spline points for the parametrised base hazard rate
approximation) were estimated for the optimal model for the N = 20000 data set. As the Bayesian model selection
stage of our analysis seeks to balance the justification for greater model complexity against the available data, it is
6An upper bound on the possible accuracy of retrospective allocation can be determined using the retrospective allocation and event
time probability relations under the assumption of an infinitely large cohort from which the parameters have been extracted perfectly;
for a cohort subject to one risk and consisting of two latent classes of equal size, with a constant class-independent base hazard rate and
only one covariate, the best possible allocation quality in the case that β111 = −β211 = 2 is about 83%.
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Figure 2: Bayesian identification and characterisation of a synthetic heterogeneous cohort: The optimal association and base hazard
rate estimates for analysis of Cohort A data, as specified in Table 3, are shown along with their true values for sample sizes N = 200,
N = 2000, and N = 20000. Our analysis correctly identifies three latent classes even for the meagre sample size of N = 200; though it is
clear on inspection of the estimates that their accuracy and precision improves with increasing sample size. The association parameters
are accurately estimated for all covariates and all classes on analysis of Cohort A data of size N = 2000; the base hazard rates deviate
only minimally from their true value at times greater than about t = 10. The precision of the estimated associations is superior for the
data set of size N = 20000 and the estimated base hazard rates are true to their actual values even beyond time t = 15.
unsurprising that models containing fewer parameters were found to be optimal for the N = 2000 and N = 200 data
sets, having 20 and 16 parameters respectively. Ultimately, there is not enough information available in the N = 200
data set to justify the selection of a model having the required complexity to accurately describe Cohort A and the
optimal model, H?KLM = (K = 3, L = 3,M = 2), is reported as having class-independent base hazard rates.
Our analysis correctly indicates that in Cohort A only covariate 1 has a statistically significant association with
hazard for the primary risk. The estimates for each of the three classes for the N = 2000 data set, for example,
are (within the estimated uncertainty) in agreement with the true values (` = 1: β111 = 1.90 ± 0.12, HR=45.96,
95% CI=[29.37,71.92], p < 10−7; ` = 2: β211 = 1.91 ± 0.11, HR=44.75, 95% CI=[28.48,70.32], p < 10−7; ` = 3:
β311 = −2.16 ± 0.14, HR=0.013, 95% CI=[0.008,0.023], p < 10−7). The associations for covariates 2 and 3 were
correctly estimated for all of the data sets, being found to be statistically insignificant (according to p-value) in all
of the three latent classes and the 95% CI included the correct HR of unity in all cases. As heterogeneity is not
accounted for in a standard Cox regression it should be expected that the application of such an analysis to Cohort
A would be likely to yield incorrect estimates. Indeed, Cox regression does produce a misleading interpretation of
the Cohort A data having N = 2000, indicating that covariates 1 and 2 are both associated with an increased hazard
(cov.1: HR=1.33, 95% CI=[1.21,1.47], p < 10−7; cov. 2: HR=1.12, 95% CI=[1.01,1.23], p=0.03).
The accuracy of the spline-approximated base hazard rates can be assessed both by visual inspection, for similarity
between the estimated and true rates (Figure 2), and numerically. The time-independent base hazard rate of the
third class (` = 3) is reliably estimated for both data the N = 20000 and N = 2000 data sets. The base hazard rates
of classes ` = 1 and ` = 2 are more accurately estimated for the larger data set size; the estimated base hazard rate
of class ` = 1 begins to deviate from the actual rate for times greater than about t = 10 for the N = 2000 analysis,
whereas deviation is not observed at times earlier than about t = 15 for the N = 20000 data set. Additionally,
the suitability of a spline-approximation to describe the exponentially increasing base hazard rate of the second
class (` = 2) can be gauged by comparing the known values of the parameters, λ0 and α, obtained on fitting the
generalised form of the exponentially increasing base hazard rate, λ(t) = λ0e
αt, to the estimated base hazard rate;
for the N = 20000 data set these parameters were determined to be λ0 = 0.012 and α = 0.233 and for the N = 2000
data set they were found to be λ0 = 0.014 and α = 0.227 (the true values of these parameters are λ0 = 0.01 and
α = 0.25).
The performance of retrospective class allocation will, of course, depend on the exact characteristics underlying a
cohort and the accuracy of the optimal model representing that cohort; it would be reasonable to expect that retro-
spective class assignment should perform most effectively when the differences between latent classes are pronounced
and that the algorithm may struggle when the latent classes do not differ significantly. The random assignment of
patients into the three classes of Cohort A would offer an accuracy of 33% whereas 73% of individuals were allocated
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Figure 3: Latent class-specific survival in a heterogeneous cohort: Survival and cumulative incidence estimates arising from the optimal
parameter estimates for analysis of Cohort A data having N = 2000. In (a) the crude and decontaminated survival curves for the primary
risk for the cohort as a whole; as there is no informative censoring in Cohort A these curves are identical. In (b) the decontaminated
survival curves, S˜1, and the Kaplan-Meier estimators, SKM1 , for the lower quartile (LQ), upper quartile (UQ), and the inter-quartile
range (IQ) of covariate 1; it is clearly apparent that proportional hazards assumption does not hold for Cohort A as a whole. In (c) the
class-specific decontaminated survival curves, S˜`1, for the three classes; the impact of the constant base hazard rate of class ` = 1 and
the exponentially increasing base hazard rate of class ` = 2 is easily observed in the difference between the survival curves for the two
classes. In (d) the stacked weighted class-specific cumulative incidence.
correctly on applying our class assignment algorithm to the N = 20000 data set; 72% and 66% of those individuals
allocated to the first and second classes (` = 1, ` = 2) actually belonged to those classes, and 84% of individuals
allocated to the third class (` = 3) actually belonged to that class. Class assignment applied to the N = 2000 data
set yielded an overall accuracy of 72% and with a similar accuracy for those assigned to the first and second class as
was obtained with the N = 20000 data set; 78% of those allocated to the third class actually belonged to that class.
It is interesting to note that for the N = 200 data set, despite there being insufficient information for all associations
and the base hazard rates to be accurately estimated, overall 70% of individuals were correctly allocated to their
true class.
In Figure 3 class-specific survival and weighted cumulative incidence functions generated using the optimal pa-
rameter estimates for the N = 2000 data set are shown. As there is only one real risk in Cohort A the crude and
decontaminated survival functions, S1 and S˜1, are identical (Figure 3 (a)). As there is no informative censoring in
Cohort A the Kaplan-Meier estimators offer a reasonable approximation to the risk-specific survival function (Fig-
ure 3 (b)); the crossing of the Kaplan-Meier estimators conditioned on the value of covariate 1 would suggest that
there is latent heterogeneity in Cohort A and that the application of standard Cox analysis would yield misleading
estimates. The differences in the expected survival between the three classes over the duration of the trial is readily
apparent on inspecting the class-specific decontaminated survival functions (Figure 3 (c)); the significantly more
rapid expiration of the first class (` = 1) against the primary risk survival in comparison to that of the second class
(` = 2) being due to the two classes having very different base hazard rates. The weighted class-specific cumulative
incidence (Figure 3 (d)) also illustrate at which stages of the trial members of the first (` = 1) and second class
(` = 2) succumb to the primary risk.
3.2 Effective analysis in the presence of informative censoring
The ability of our analysis to accurately model the true survival in the presence of heterogeneity-induced informative
censoring is now examined. The analysis of two cohorts having identical primary risk characteristics are presented
in this section; one cohort being modelled to include the effects of false protectivity and the other to include the
influence of false-aetiology.
Both Cohort B and Cohort C have two latent classes (L = 2) of equal size and have personalised cause-specific
hazard rates having class-dependent associations (i.e. of type M = 2); both are subject to two real risks, the primary
risk (r = 1) and a competing risk (r = 2), and end-of-trial censoring. The base hazard rates are time-independent
but differ between the two risks. The properties of Cohort B and Cohort C are given in Table 4 alongside the
Bayesian-determined optimal parameter values for data having N = 1500 observations.
The optimal model was correctly determined for the analysis of both Cohort A and Cohort B data, describing
heterogeneous cohorts containing two classes and with personalised hazard rates having heterogeneous associations
but with class-independent and time-independent base hazard rates. The predicted class sizes, associations, and base
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Table 4: Modelling heterogeneity-induced informative censoring: The estimated weights, w`, and association param-
eters, β`µr , for the two real risks r = 1 and r = 2, from the Bayesian-determined optimal model from analysis of the
Cohort B and Cohort C data sets with N = 1500. The true parameter values are shown in brackets to the right of
the estimated values.
Cohort B (K = 1, L = 2,M = 2)
Heterogeneity-induced false protectivity
Class, ` = 1 Class, ` = 2
w` 0.51± 0.02 (0.5) 0.49± 0.02 (0.5)
β`11 1.85± 0.14 (2.0) −1.97± 0.10 (-2.0)
β`21 −0.05± 0.10 (0.0) −0.04± 0.07 (0.0)
β`31 0.15± 0.10 (0.0) 0.01± 0.09 (0.0)
β`12 3.17± 0.10 (3.0) −0.10± 0.07 (0.0)
β`22 −0.07± 0.08 (0.0) 0.03± 0.06 (0.0)
β`32 −0.06± 0.07 (0.0) 0.01± 0.06 (0.0)
Cohort C (K = 1, L = 2,M = 2)
Heterogeneity-induced false aetiology
Class, ` = 1 Class, ` = 2
w` 0.51± 0.02 (0.5) 0.49± 0.02 (0.5)
β`11 2.04± 0.12 (2.0) −1.94± 0.10 (-2.0)
β`21 −0.06± 0.07 (0.0) −0.01± 0.06 (0.0)
β`31 −0.02± 0.08 (0.0) 0.14± 0.06 (0.0)
β`12 −3.02± 0.09 (-3.0) 0.11± 0.08 (0.0)
β`22 −0.02± 0.06 (0.0) 0.05± 0.07 (0.0)
β`32 0.04± 0.07 (0.0) −0.03± 0.06 (0.0)
hazard rates for both data sets were in close agreement with their actual values, as detailed in Table 4.
The Bayesian-determined estimates for both Cohort B and Cohort C suggest correctly that covariate 1 is strongly
associated with an increased hazard for the primary risk in one class and is associated with a reduced hazard in the
other class; covariates 2 and 3 were found to be statistically insignificant, according to their respective p-values, for
both classes in both cohorts.
The Bayesian-determined estimates for the secondary risk, responsible for informative censoring, were also found
to be consistent with the expected values for both cohorts. In Cohort B covariate 1 was found to be strongly associated
with an increased hazard for the secondary risk in one class only (` = 1: HR=565.28, 95% CI=[387.72,824.17],
p = 10−7), and in Cohort C covariate 1 was found to be associated with a reduced hazard for the secondary risk for
one class only (` = 1: HR=0.002, 95% CI=[0.002,0.003], p = 10−7). Again, the associations for the other covariates
were found to be statistically insignificant and the predicted hazard ratios suggested neither elevated or reduced
hazard for the secondary risk.
It is reassuring that our analysis was able to correctly characterise the associations for the primary risk as being
identical (within the estimated uncertainty of the parameter estimates) both in the presence of heterogeneity-induced
false protectivity (Cohort B) and in the presence of heterogeneity-induced false aetiology (Cohort C ). As was found
in Section 3.1 for the analysis of heterogeneous cohort data, standard Cox regression offered misleading estimates on
the analysis of Cohort B and Cohort C data.
The various survival estimators obtained with the optimal parameter estimates for Cohort B are shown in Figure 4.
False protectivity in the cohort is clearly indicated (Figure 4 (a)); the crude survival function for the primary risk,
S1, exceeds its decontaminated counterpart, S˜1, consequently true survival against the primary risk is poorer than
the crude survival function suggests. In the presence of informative censoring the Kaplan-Meier estimators for the
primary risk, SKM1 , conditioned on the value of covariate 1, are also seen to be misleading (Figure 4 (b)); the risk-
specific Kaplan-Meier estimators follow the crude survival function (not shown) and yield extremely poor estimates
for the lower and upper quartiles of covariate 1 due to risk correlations in the cohort. The Kaplan-Meier estimator, for
example, indicates that individuals having an upper quartile value of covariate 1 are likely to have a relatively good
survival (about 90% surviving at the end-of-trial time) against the primary risk whereas such individuals actually
have a much poorer survival (less than 50% survival at the end-of-trial time). The class-specific survival functions
and weighted class-specific cumulative incidence are also shown (Figure 4 (c,d)).
In Figure 5 the survival estimators for Cohort C are shown. The influence of false aetiology effects in Cohort
C is clear on noting that the decontaminated survival function for the primary risk, S˜1, exceeds the crude survival
function, S1, throughout the trial duration; the true survial against the primary risk is significantly greater than
the crude survival function suggests. The covariate-conditioned risk-specific Kaplan-Meier estimators prove also to
be very misleading in the presence of false exposure effects in Cohort C ; the Kaplan-Meier estimator for individuals
having a lower quartile value of covariate 1 suggests no survival beyond about half of the trial duration whereas the
survival for such individuals is actually almost 50% at the end-of-trial time. The class-specific survival functions and
weighted class-specific cumulative incidence are also shown (Figure 5 (c,d)).
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Figure 4: Decontaminating false protectivity effects from survival data: Survival and cumulative incidence curves for analysis of Cohort
B (Table 4) data having N = 1500 demonstrating the effectiveness of our analysis to expose the influence of false protectivity in survival
data. In (a) the crude and decontaminated risk-specific survival curves, Sr(t) and S˜r(t), for the primary and secondary risks; the extent
to which the secondary risk causes false protectivity is clearly apparent on observing the difference between the crude and decontaminated
survival curves for the primary risk. In (b) the decontaminated survival curves, S˜1, and the risk-specific Kaplan-Meier estimators, SKM1 ,
for the lower quartile (LQ), upper quartile (UQ), and the inter-quartile range (IQ) of covariate 1; it is clear that proportional hazards
assumption does not hold for Cohort B as a whole and it is striking that the risk-specific Kaplan-Meier estimator for the upper quartile
of covariate 1 is extremely misleading. In (c) the class- and risk-specific decontaminated survival curves, S˜`r, for the two latent classes for
both risks. In (d) the stacked weighted class-specific cumulative incidence.
4 Applications to prostate cancer data
Prostate cancer (PC) data are notorious for exhibiting competing risk effects [40], largely due to the fact that the
disease occurs late in life when there is an increased number of non-primary events whose incidence could correlate
with prostate cancer. Here we analyse data from the ULSAM cohort [35] and compare the outcomes of Cox’s
proportional hazards regression [11] and our present method. The ULSAM cohort has N = 2047 individuals of
which 208 reported PC as the first event as described previously [36] and we have included five relevant covariates
of the ULSAM data [35].7
Smoking is suggested to have a weak protective effect against PC risk (HR=0.85, 95% CI=[0.65,1.11], p=0.23)
in the ULSAM cohort according to Cox’s proportional hazards analysis. However, as the Kaplan-Meier estimator
for PC risk conditioned on the smoking covariate (see Figure 1) does not meet the proportional hazards assumption,
any conclusions drawn from such an analysis (on the ULSAM cohort data as a whole, at least) may be invalid.
The non-proportionality of the smoking covariate-conditioned Kaplan-Meier estimator for PC risk could be due to
heterogeneity in the ULSAM cohort.
The optimal characterisation of the ULSAM data, as determined by Bayesian model selection, suggests that the
cohort should be viewed as consisting of two distinct classes: one class ` = 1 with relatively frail individuals (in
terms of both primary and secondary risk) which contains about 16% of the cohort according to retrospective class
allocation, and another class ` = 2 with rather healthy individuals which contains the remainder of the cohort. The
estimated association parameters, base hazard rates, and class-specific survival functions for PC are shown in Fig. 6
for the most probable model (H?KLM = (K = 3, L = 2,M = 2)). The decontaminated survival function for PC was
found to be marginally less than the crude survival function for follow-up times exceeding about 20 years; this is
indicative of false protectivity effects for PC risk in the ULSAM cohort data.
In the Bayesian-determined two-class description of the ULSAM cohort, BMI and smoking are recognised as
serious PC risk factors for those individuals in the healthier class. In the healthier class (` = 2) smoking is associated
with elevated risk of PC (HR=4.08, 95% CI=[1.09,15.29], p=0.04), as is having a higher BMI (HR=2.77, 95%
CI=[1.20,6.36], p=0.02). Conversely, in the frailer class (` = 1) smoking is associated with a decreased risk of PC
(HR=0.30, 95% CI=[0.12,0.76], p=0.01). In the frail class the regression coefficients are weaker than those of the
stronger class, and one expects the negative coefficients for e.g. BMI and smoking to reflect reverse causality: within
this group, having a higher BMI and still being able to smoke may well be an indicator of relatively good health.
Our explanation of the ULSAM data is not necessarily the final one. There are alternative ways to do the
regression, e.g. by combining all non-primary risks (including the end-of-trial risk). The conclusion to be drawn is
that the new two-class explanation of the ULSAM data is both probabilistically and intuitively more plausible.
7Since this study does not seek to answer a pre-specified clinical hypothesis, the actual choice made for the set of covariates to be
included is not critical.
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Figure 5: Decontaminating false aetiology effects from survival data: Survival and cumulative incidence curves for analysis of Cohort
C (Table 4) data having N = 1500 demonstrating the effectiveness of our analysis to expose the influence of false aetiology in survival
data. In (a) the crude and decontaminated risk-specific survival curves, Sr(t) and S˜r(t), for the primary and secondary risks; the extent
to which the secondary risk suggests false exposure is clearly apparent on observing the difference between the crude and decontaminated
survival curves for the primary risk. In (b) the decontaminated survival curves, S˜1, and the risk-specific Kaplan-Meier estimators, SKM1 ,
for the lower quartile (LQ), upper quartile (UQ), and the inter-quartile range (IQ) of covariate 1; it is clear that proportional hazards
assumption does not hold for Cohort C as a whole and that the risk-specific Kaplan-Meier estimator for the lower quartile of covariate
1 is extremely misleading. In (c) the class- and risk-specific decontaminated survival curves, S˜`r, for the two latent classes for both risks.
In (d) the stacked weighted class-specific cumulative incidence.
5 Applications to breast cancer data
In this section the results of the application of our analysis to data from the Swedish Apolipoprotein Mortality Risk
Study (AMORIS) e.g. [37, 38] are summarised. The analysed data set is that for which a competing risk analysis is
presented in [41], and contained data for N = 1798 women from the AMORIS population for whom baseline serum
glucose, triglyceride, and total cholesterol measurements were available within three months to three years prior to
breast cancer diagnosis. The time-to-event describes the duration between diagnosis and breast cancer death (BC),
cardiovascular disease death (CV), death from other causes, or departure from or the end of the study (censoring)
and age, fasting status, and socio-economic status data were also included as covariates.
Our analysis suggests that the cohort of women from the AMORIS population diagnosed with breast cancer is
best described by three latent classes which share the same general trend of having base hazard rates which decrease
with time for BC death risk but increase with time for CV death risk. The largest class (` = 1) contains about 66%
of the cohort according to retrospective class allocation and has a poorer survival against BC death but a greater
survival against CV death than does the second class (` = 2), which accounts for 32% of the cohort. The smallest
latent class (` = 3) is almost wholly comprised of relatively younger individuals for whom death from other causes
was reported; it is likely that the inclusion of this third class, containing only 35 of the 1798 individuals according to
retrospective class assignment, enables more effective characterisation of the other two classes as it allows the effects
of two differing groups within those reported as having death from other causes to be distinguished. As BC and CV
death shall be the focus of the remainder of this section, parameter estimates and survival curves pertaining to the
small third latent class (` = 3) are omitted in the interest of readability. The estimated associations, base hazard
rates, and decontaminated class-specific survival curves are shown in Figure 7 for the optimal characterisation of this
cohort.
The largest class (` = 1) has the greatest hazard for BC death, having a base hazard rate which exceeds that
of the second class (` = 2) over the entire interval (Figure 7 (c)); the opposite is true for the hazard for CV death,
with the second class (` = 2) having the greatest hazard for CV death. The base hazard rate for BC death is most
significant at diagnosis (t = 0) and diminishes with time whereas the risk of CV death increases with time. The
base hazard for CV death exceeds the risk of BC death after about 20 years from diagnosis for those in the first
class (` = 1) and after about 16 years for those in the second class (` = 2); this is generally consistent with previous
findings regarding the importance of considering co-morbidities for women with breast cancer [42]. Accordingly,
survival against BC death is greater for the less frail second class (` = 2) than for the first class (` = 1) and survival
against CV death is greater in the first class (` = 1) than in the second class (` = 2).
In the relatively frail first class (` = 1), triglyceride levels were found to be associated with an increased hazard for
both CV death (CV, ` = 1: HR=6.44, 95% CI=[1.86,22.29], p = 0.003) and for BC death (BC, ` = 1: HR=1.62, 95%
CI=[0.92,2.84], p = 0.09). Standard Cox analysis suggests a weaker association with an increased hazard against CV
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Figure 6: Bayesian-determined heterogeneous characterisation of the ULSAM cohort: In (a) and (b) the associations and frailty
weighted-base hazard rates for PC risk, for the two latent classes of the optimal model H?KLM = (K = 3, L = 2,M = 2) obtained on
analysis of the ULSAM cohort data. The included covariates are: body mass index (real-valued), serum Selenium level (selen, integer
valued), leisure time physical activity (phys1, discrete levels 0/1/2), work physical activity (phys2, discrete levels 0/1/2), and smoking
status (smoking, discrete levels 0/1/2). The estimated weighting of the classes for this model is w1 = 0.32± 0.08, w2 = 0.68± 0.08. The
retrospective weighting of the classes for this model is f1 = 0.16 (332 of 2047 patients), f2 = 0.84 (1715 of 2047 patients). In (c) the
class-and risk-specific survival functions; for PC risk it is clear that the survival of members of the frailer class (` = 1) is poorer than
those of the healthier class (` = 2), significantly and increasingly so for times beyond about 20 years. In (d) the class-and risk-specific
survival function conditioned on the three values of the smoking covariate (z5 = 0: non-smoker, z5 = 1: ex-smoker, z5 = 2: smoker); it is
clear that for the majority of the cohort (` = 2) smoking is associated with poorer survival outcomes but that for those members of the
frailer class (` = 1) smokers and ex-smokers have greater survival than non-smokers.
death (CV, Cox: HR=1.61, 95% CI=[1.17,2.21], p = 0.003) than is suggested by our analysis, a probable consequence
of those members of the cohort for which triglyceride levels are not associated with increased hazard (` = 2) diluting
the effects of those for which triglyceride levels are associated with increased hazard (` = 1); the same is also true for
BC death, for which standard Cox analysis indicates that triglyceride levels are associated with a modestly increased
hazard for BC death (BC, Cox: HR=1.22, 95% CI [0.98,1.52], p=0.076). Serum glucose was found to be associated
with an increased hazard for CV death (CV, ` = 2: HR=1.59, 95% CI=[1.01,2.49], p = 0.04) for those in the relatively
less frail second class (` = 2), as was total cholesterol (CV, ` = 2: HR=1.65, 95% CI=[0.79,3.51], p = 0.18).
In contrast to standard Cox analysis, which suggests that age is associated with a reduced hazard for BC death
(BC, Cox: HR=0.77, 95% CI=[0.59,1.00], p=0.05) for the cohort as a whole, our analysis indicates that for the
majority of the cohort (` = 1) age is associated with an increased hazard for BC death (BC, ` = 1: HR=3.49,
95% CI=[1.51,8.10], p=004) and is associated with a reduced hazard for BC death (BC, ` = 2: HR=0.09, 95%
CI=[0.02,0.30], p ≈ 10−4) for about only one third of the cohort (` = 2). The age of an individual was also found to
be associated with their hazard for CV death, most significantly being strongly associated with an increased hazard
for CV death (CV, ` = 2: HR=42.93, 95% CI=[16.43,112.21], p < 10−7) in the less frail second class (` = 2).
The age-conditioned risk-specific Kaplan-Meier estimator and class-specific decontaminated survival for BC death
are shown in Figure 8, along with the age, time-to-event, and retrospectively assigned class, for those individuals
recorded as succumbing to BC death. The stratification by age, between about 50 and 55 years, of those individuals
succumbing to BC death and retrospectively allocated to the relatively frail class (` = 1) and those allocated to the
second class (` = 2), suggest that menopausal status may be informative as to expected survival against BC death,
as shown in Figure 8(c).
Survival against BC death for the more frail first class (` = 1) is greatest for the younger members of the cohort,
with over 80% survival for those in the LQ for age in the cohort as opposed to less than 50% survival for those in
the UQ for age. In the second class (` = 2) survival against BC death is markedly poorer for younger members of
the cohort as a consequence of age being strongly associated with reduced hazard for BC death for this class.
6 Discussion
In this study we have introduced a fully Bayesian approach for the determination of the probabilistically optimal
characterisation of a complex cohort. The introduction of the concept of heterogeneity-induced informative censoring,
where risks are independent only at the level of individuals, has enabled us to identify the ‘decontaminated’ hazard
rates and survival functions.
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Figure 7: Bayesian-determined heterogeneous characterisation of a cohort of women from the AMORIS population diagnosed with
breast cancer: Parameter estimates for the Bayesian-determined optimal model, H?KLM = (K = 3, L = 3,M = 2), obtained on analysis
of data for N = 1798 women from the AMORIS population diagnosed with breast cancer; the estimated retrospective weighting of the
classes for this model is f1 = 0.66 (1189 of 1798 patients), f2 = 0.32 (574 of 1798 patients), f3 = 0.02 (35 of 1798 patients). In (a) and
(b) the estimated hazard associations, β`µr , with serum glucose, triglyceride (TG), total cholesterol (TC) and age, for BC death (r = 1)
and CV death (r = 2) respectively for the dominant (` = 1: red) and next largest (` = 2: green) latent classes. In (c) the base hazard
rates for BC and CV death for the two dominant latent classes; note that the base hazard rate for CV death exceeds that for BC death
for follow-up times greater than about 15 years (` = 1: red, ` = 2: green). In (d) the crude (solid lines) and decontaminated (dashed
lines) cause-specific survival against BC (red lines) and CV death (green lines); observe that the crude survival against CV death, S2, is
poorer than its decontaminated counterpart, S˜2.
The software package, ALPACA, which implements the formalism introduced herein provides practical tools
for survival analysis which can be applied to heterogeneous cohorts and in the presence of heterogeneity-induced
informative censoring. This implementation is able to find the most probable characterisation of a cohort through
the combination of i) a latent class model which captures, for all risks and for each class, the base hazard rate,
covariate association(s) and relative frailty, and ii) Bayesian model selection to determine the optimal number of
classes, the optimal parametrisation of each base hazard rate, and the extent of heterogeneity in the cohort. Once
the optimal description of the cohort has been determined, crude and decontaminated cause-specific survival curves
can be compared to gauge the extent of any informative censoring, and differences between class-specific survival
curves can be examined. Exploration of correlations between covariate values and retrospectively assigned class
membership can offer an extra insight into a cohort and may aid the search for new informative biomarkers. An
additional advantage of our approach is that through the incorporation of Bayesian model selection to determine the
optimal description of a cohort, our survival analysis can be applied with little interaction or effort required from
the analyst prior to inspection and assessment of the frailties, covariate association(s), and base hazard rates for the
optimal model.
Applied to synthetic data, our analysis was shown to effectively characterise heterogeneous cohorts, successfully
remove heterogeneity-induced false protectivity and false aetiology effects, and even discriminate between two classes
differing only in their base hazard rates. Retrospective class allocation was demonstrated to have an impressive
accuracy even for survival data modelling a cohort containing 200 individuals.
On application to real survival data from the ULSAM cohort, with prostate cancer as the primary risk, our analysis
leads to plausible alternative explanations for previous counter-intuitive inferences (such as a weak protective effect
on PC of smoking), in terms of distinct sub-groups of patients with distinct risk factors and overall frailties. In the
ULSAM cohort, it was also shown that the men’s metabolic status introduce competing risk problems, although
using traditional methods, several different analyses had to be done to reveal the underlying risk pattern [40], which
with our proposed method could be done coherently in one analysis.
Applied to survival data for women diagnosed with breast cancer from the Swedish Apolipoprotein Mortality
Risk Study (AMORIS), our analysis suggests that for breast cancer death risk the base hazard rate decreases with
time but increases with time for cardiovascular death risk, and the age-class membership correlations may suggest
differences in association patterns and survival against breast cancer between pre- and post-menopausal women.
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Figure 8: Age and survival in women from the AMORIS population diagnosed with breast cancer: In (a) the age-conditioned Kaplan-
Meier estimator for BC death; observe that survival of both the upper and lower quartiles of age the proportional hazards is poorer than
that for the inter-quartile range for age (i.e. the proportional hazards assumption is not met) and is suggestive of heterogeneity in the
cohort. In (b) the class-specific decontaminated survival curves, S˜`r conditioned on the age covariate (z4), for BC death (r = 1). The
substantial difference in survival against BC death between those in the lower quartile (LQ) and upper quartile (UQ) for age is indicative
of the strength of the association of age with hazard for BC death (see Figure 7). Observe that in the more frail first class (` = 1) survival
against BC death decreases with increasing age while the opposite is true of the second class (` = 2); however, survival of the second
class (` = 2) is actually poorer for younger individuals than it is for older from the more frail first class (` = 1). In (c) the time-to-event
and age for each individual having succumbed to BC death is shown, indicating that there is a clear stratification, according to age, of
the latent classes to which individuals are retrospectively assigned. Almost all of those individuals younger than about 50 years old are
assigned to the second latent class (` = 2) whereas those older than about 50 years are assigned to the first class (` = 1).
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A Latent class model: additional details and identities
A.1 Connection between cohort level and individual level cause-specific hazard rates
The relationship between the cohort level covariate-conditioned cause-specific hazard rate, hr(t|z), and the haz-
ard rates of the individual members of the cohort, hir(t), is obtained by substitution of P(t0, . . . , tR|z) =∑
i, zi=z
Pi(t0, . . . , tR)/
∑
i, zi=z
1 into (2), to give,
hr(t|z)S(t|z) =
∑
i, zi=z
∫∞
0
. . .
∫∞
0
dt0 . . . dtR Pi(t0, . . . , tR)δ(t− tr)
∏R
r′ 6=r θ(tr′ − t)∑
i, zi=z
1
=
∑
i, zi=z
Si(t)h
i
r(t)∑
i, zi=z
1
.
Insertion of the identity S(t|z) = ∑i, zi=z Si(t)/∑i, zi=z 1 and the individualised survival function, Si(t) =
e−
∑
r
∫ t
0
ds hir(s), into the above leads to the relationship expressed by (3).
A.2 Equivalence of crude and decontaminated survival in the absence of competing
risks
In the case that a cohort is exposed to only one risk the crude and decontaminated survival, Sr(t) and S˜r(t)
respectively (6), are equivalent, as shown below.
As only one risk is present (i.e. R = 1), the crude and decontaminated cohort-level hazard rates, h1(t|z) and
h˜1(t|z) respectively (5), are identical. As the crude and decontaminated survival are initially equal, Sr(t = 0) =
S˜r(t = 0) = 1, in order to prove that in the absence of any competing risks are the same at any time t it is sufficient
to show that their time derivatives are also equal, as follows,
d
dt
[
lnS1(t|z)− ln S˜1(t|z)
]
= −h1(t|z) +
∑
i,zi=z
hi1(t)e
∫ t
0
dshi1(s)∑
i,zi=z
e
∫ t
0
dshi1(s)
= −h1(t|z) + h1(t|z) = 0.
A.3 Bayesian retrospective class assignment
Bayesian arguments allow us to calculate class membership probabilities retrospectively8 for any individual for whom
we have their covariates z and survival information (t, r). The probability of an individual belonging to class `,
conditioned on their covariates and survival information, follows from (12), and is given by,
P (t, r|z, `) = e−Λ0(t) λ`r(t)eβ
`
r·z−
∑R
r′=1 exp(β
`
r′ ·z)Λ`r′ (t).
Given that P (t, r, `|z) = P (t, r|z, `)w` and P (t, r|z) =
∑L
`′=1 P (t, r|z, `′)w`′ , it follows that the probability of an
individual belonging to class ` is given by,
P (`|t, r, z) = w`P (t, r|z, `)∑L
`′=1 w`′P (t, r|z, `′)
. (17)
Substitution of P (t, r|z, `) into the above expression leads to the retrospective class membership probability, as is
given for the fully heterogeneous model variant (M = 3) in (11).
A.4 Prior distributions for the latent class model parameters
In seeking the optimal characterisation of a cohort using Bayesian inference (Section 2.5) it is necessary that a prior
distribution, p(θKLM ), on the latent class model parameters, θKLM , be defined. This requires that suitable prior
distributions be chosen to encode any available information regarding the weights, frailties, associations, and those
parameters used in the base hazard rate approximation.
The maximum entropy prior on the L weight parameters has been used, following from the constraint
∑
` w` = 1,
and is given by p(w1, . . . , wL) = 1/ZL, where ZL =
∫ 1
0
dw1 . . .
∫ 1
0
dwL δ(
∑
` w` − 1) = 1/(L − 1)!. Unit-variance
zero-average Gaussian priors were chosen for the frailty and association parameters; this is justified by our decision
to pre-process the data such that all covariate distributions are normalised (by linear rescaling) to zero average and
unit variance over the cohort.
8As our latent classes are defined in terms of the relation between covariates and risk, class membership for individuals cannot be
predicted on the basis of covariate information alone.
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A.5 Model evidence determination using a Gaussian approximation
To find the optimal characterisation of a cohort using Bayesian model selection requires that the model supported
by the greatest “evidence” be determined. The posterior distribution can be written as P (θ|D) = Z−1KLMe−S(θ,D),
where S(θ, D) = − ln[P (θ|HKLM )P (D|θ,HKLM )], and the model evidence is proportional to ZKLM , as given by
ZKLM =
∫
dθ P (θ|HKLM )P (D|θ,HKLM ). (18)
In our analysis, determination of the evidence (the volume of the posterior) is achieved via a Gaussian approxi-
mation to the posterior by making a Taylor expansion around its maximum, as described in e.g. [43]. The posterior
is approximated by P (θ|D,HKLM ) = Z−1KLM exp[−S(θ?) − (θ − θ?).A(θ − θ?)/2], where θ? is the location of its
maximum and A is the Hessian matrix. The Gaussian-approximation for (18), Z?KLM , is obtained by integrating
over the normalised approximated posterior distribution and recalling the standard form for a Gaussian integral, and
is given by,
Z?KLM = e
−S(θ?)(2pi)Y/2(detA)−1/2, (19)
where Y is the dimensionality of θ. In this work, the matrix A is estimated numerically by investigating the curvature
of the posterior distribution around its maximum.
B Generation of synthetic time-to-event data
Synthetic data having risks that are independent at the level of individuals and with individual cause-specific hazard
rates of the form given in Table 2 was generated as described below.
The latent class, ` ∈ 1, . . . , L, to which each individual, i = 1, . . . , N , belongs is set at the time of generation.
Covariate values for each individual, zµi ∈ N (0, 1), were generated independently from a normal distribution having
zero average and unit variance. A latent event time, tri , was generated for each individual and for each risk, r = 1 . . . R,
according to tri (u) = Λ
`,inv
r (e
−β`r.zi log(u)) where Λ`,invr (v) is the inverse of Λ
`
r(t) =
∫ t
0
ds λ`r(s) and u ∈ [0, 1] is a
uniformly distributed random variable. The survival data for individual i is that for which the latent event time is
smallest ti = minr∈{1,...,R}tri . Should ti exceed the trial duration then individual i assumes the end-of-trial censoring
event and trail duration.
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